Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Healthcare Cold Chain Logistics Market

ID: MRFR/HC/43350-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Japan Healthcare Cold Chain Logistics Market Research Report By Mode of Delivery (Last-Mile Delivery, Hubs-to-Distributor), By Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials), By Services (Transportation, Storage, Packaging, Labeling, Others), By End User (Hospitals Clinics, Pharmaceutical, Biopharmaceutical, Biotechnology Companies, Others) and By Temperature Range (Ambient, Refrigerated, Frozen, Cryogenic) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Healthcare Cold Chain Logistics Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Pharmaceuticals
  50.     4.1.2 Biologics
  51.     4.1.3 Vaccines
  52.     4.1.4 Clinical Trials
  53.     4.1.5 Blood and Blood Products
  54.   4.2 Healthcare, BY End Use (USD Million)
  55.     4.2.1 Hospitals
  56.     4.2.2 Pharmacies
  57.     4.2.3 Research Laboratories
  58.     4.2.4 Biotechnology Companies
  59.     4.2.5 Logistics Providers
  60.   4.3 Healthcare, BY Temperature Range (USD Million)
  61.     4.3.1 Ambient Temperature
  62.     4.3.2 Refrigerated Temperature
  63.     4.3.3 Frozen Temperature
  64.     4.3.4 Ultra-Low Temperature
  65.   4.4 Healthcare, BY Packaging Type (USD Million)
  66.     4.4.1 Insulated Containers
  67.     4.4.2 Thermal Pallets
  68.     4.4.3 Temperature-Controlled Boxes
  69.     4.4.4 Phase Change Materials
  70.   4.5 Healthcare, BY Transport Mode (USD Million)
  71.     4.5.1 Air Freight
  72.     4.5.2 Road Transport
  73.     4.5.3 Sea Freight
  74.     4.5.4 Rail Transport
  75. 5 SECTION V: COMPETITIVE ANALYSIS
  76.   5.1 Competitive Landscape
  77.     5.1.1 Overview
  78.     5.1.2 Competitive Analysis
  79.     5.1.3 Market share Analysis
  80.     5.1.4 Major Growth Strategy in the Healthcare
  81.     5.1.5 Competitive Benchmarking
  82.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  83.     5.1.7 Key developments and growth strategies
  84.       5.1.7.1 New Product Launch/Service Deployment
  85.       5.1.7.2 Merger & Acquisitions
  86.       5.1.7.3 Joint Ventures
  87.     5.1.8 Major Players Financial Matrix
  88.       5.1.8.1 Sales and Operating Income
  89.       5.1.8.2 Major Players R&D Expenditure. 2023
  90.   5.2 Company Profiles
  91.     5.2.1 DHL Supply Chain (JP)
  92.       5.2.1.1 Financial Overview
  93.       5.2.1.2 Products Offered
  94.       5.2.1.3 Key Developments
  95.       5.2.1.4 SWOT Analysis
  96.       5.2.1.5 Key Strategies
  97.     5.2.2 Kuehne + Nagel (JP)
  98.       5.2.2.1 Financial Overview
  99.       5.2.2.2 Products Offered
  100.       5.2.2.3 Key Developments
  101.       5.2.2.4 SWOT Analysis
  102.       5.2.2.5 Key Strategies
  103.     5.2.3 Nippon Express (JP)
  104.       5.2.3.1 Financial Overview
  105.       5.2.3.2 Products Offered
  106.       5.2.3.3 Key Developments
  107.       5.2.3.4 SWOT Analysis
  108.       5.2.3.5 Key Strategies
  109.     5.2.4 Yamato Transport (JP)
  110.       5.2.4.1 Financial Overview
  111.       5.2.4.2 Products Offered
  112.       5.2.4.3 Key Developments
  113.       5.2.4.4 SWOT Analysis
  114.       5.2.4.5 Key Strategies
  115.     5.2.5 SBS Holdings (JP)
  116.       5.2.5.1 Financial Overview
  117.       5.2.5.2 Products Offered
  118.       5.2.5.3 Key Developments
  119.       5.2.5.4 SWOT Analysis
  120.       5.2.5.5 Key Strategies
  121.     5.2.6 Mitsubishi Logistics (JP)
  122.       5.2.6.1 Financial Overview
  123.       5.2.6.2 Products Offered
  124.       5.2.6.3 Key Developments
  125.       5.2.6.4 SWOT Analysis
  126.       5.2.6.5 Key Strategies
  127.     5.2.7 Kintetsu World Express (JP)
  128.       5.2.7.1 Financial Overview
  129.       5.2.7.2 Products Offered
  130.       5.2.7.3 Key Developments
  131.       5.2.7.4 SWOT Analysis
  132.       5.2.7.5 Key Strategies
  133.     5.2.8 Seino Holdings (JP)
  134.       5.2.8.1 Financial Overview
  135.       5.2.8.2 Products Offered
  136.       5.2.8.3 Key Developments
  137.       5.2.8.4 SWOT Analysis
  138.       5.2.8.5 Key Strategies
  139.     5.2.9 Hitachi Transport System (JP)
  140.       5.2.9.1 Financial Overview
  141.       5.2.9.2 Products Offered
  142.       5.2.9.3 Key Developments
  143.       5.2.9.4 SWOT Analysis
  144.       5.2.9.5 Key Strategies
  145.   5.3 Appendix
  146.     5.3.1 References
  147.     5.3.2 Related Reports
  148. 6 LIST OF FIGURES
  149.   6.1 MARKET SYNOPSIS
  150.   6.2 JAPAN MARKET ANALYSIS BY APPLICATION
  151.   6.3 JAPAN MARKET ANALYSIS BY END USE
  152.   6.4 JAPAN MARKET ANALYSIS BY TEMPERATURE RANGE
  153.   6.5 JAPAN MARKET ANALYSIS BY PACKAGING TYPE
  154.   6.6 JAPAN MARKET ANALYSIS BY TRANSPORT MODE
  155.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  156.   6.8 RESEARCH PROCESS OF MRFR
  157.   6.9 DRO ANALYSIS OF HEALTHCARE
  158.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  159.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  160.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  161.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  162.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  163.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  164.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  165.   6.17 HEALTHCARE, BY TEMPERATURE RANGE, 2024 (% SHARE)
  166.   6.18 HEALTHCARE, BY TEMPERATURE RANGE, 2024 TO 2035 (USD Million)
  167.   6.19 HEALTHCARE, BY PACKAGING TYPE, 2024 (% SHARE)
  168.   6.20 HEALTHCARE, BY PACKAGING TYPE, 2024 TO 2035 (USD Million)
  169.   6.21 HEALTHCARE, BY TRANSPORT MODE, 2024 (% SHARE)
  170.   6.22 HEALTHCARE, BY TRANSPORT MODE, 2024 TO 2035 (USD Million)
  171.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  172. 7 LIST OF TABLES
  173.   7.1 LIST OF ASSUMPTIONS
  174.     7.1.1
  175.   7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  176.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  177.     7.2.2 BY END USE, 2026-2035 (USD Million)
  178.     7.2.3 BY TEMPERATURE RANGE, 2026-2035 (USD Million)
  179.     7.2.4 BY PACKAGING TYPE, 2026-2035 (USD Million)
  180.     7.2.5 BY TRANSPORT MODE, 2026-2035 (USD Million)
  181.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  182.     7.3.1
  183.   7.4 ACQUISITION/PARTNERSHIP
  184.     7.4.1

Japan Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

  • Pharmaceuticals
  • Biologics
  • Vaccines
  • Clinical Trials
  • Blood and Blood Products

Healthcare By End Use (USD Million, 2026-2035)

  • Hospitals
  • Pharmacies
  • Research Laboratories
  • Biotechnology Companies
  • Logistics Providers

Healthcare By Temperature Range (USD Million, 2026-2035)

  • Ambient Temperature
  • Refrigerated Temperature
  • Frozen Temperature
  • Ultra-Low Temperature

Healthcare By Packaging Type (USD Million, 2026-2035)

  • Insulated Containers
  • Thermal Pallets
  • Temperature-Controlled Boxes
  • Phase Change Materials

Healthcare By Transport Mode (USD Million, 2026-2035)

  • Air Freight
  • Road Transport
  • Sea Freight
  • Rail Transport

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓